[1] |
QI X. Portal vein thrombosis: Recent advance[J]. Adv Exp Med Biol, 2017, 906: 229-239. DOI: 10.1007/5584_2016_118.
|
[2] |
ABDEL-RAZIK A, MOUSA N, ELHELALY R, et al. De-novo portal vein thrombosis in liver cirrhosis: Risk factors and correlation with the Model for End-stage Liver Disease scoring system[J]. Eur J Gastroenterol Hepatol, 2015, 27(5): 585-592. DOI: 10.1097/MEG.0000000000000325.
|
[3] |
NORONHA FERREIRA C, MARINHO RT, CORTEZ-PINTO H, et al. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study[J]. Liver Int, 2019, 39(8): 1459-1467. DOI: 10.1111/liv.14121.
|
[4] |
CHAWLA Y, DUSEJA A, DHIMAN RK. Review article: The modern management of portal vein thrombosis[J]. Aliment Pharmacol Ther, 2009, 30(9): 881-894. DOI: 10.1111/j.1365-2036.2009.04116.x.
|
[5] |
OKUDA K, OHNISHI K, KIMURA K, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients[J]. Gastroenterology, 1985, 89(2): 279-286. DOI: 10.1016/0016-5085(85)90327-0.
|
[6] |
MARUYAMA H, OKUGAWA H, TAKAHASHI M, et al. De novo portal vein thrombosis in virus-related cirrhosis: Predictive factors and long-term outcomes[J]. Am J Gastroenterol, 2013, 108(4): 568-574. DOI: 10.1038/ajg.2012.452.
|
[7] |
ENGLESBE M J, KUBUS J, MUHAMMAD W, et al. Portal vein thrombosis and survival in patients with cirrhosis[J]. Liver Transpl, 2010, 16(1): 83-90. DOI: 10.1002/lt.21941.
|
[8] |
STINE JG, SHAH PM, CORNELLA SL, et al. Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis[J]. World J Hepatol, 2015, 7(27): 2774-2780. DOI: 10.4254/wjh.v7.i27.2774.
|
[9] |
GAO B, XIAO J, ZHANG M, et al. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: A retrospective study[J]. Lipids Health Dis, 2019, 18(1): 79. DOI: 10.1186/s12944-019-1005-8.
|
[10] |
LV Y, QI X, HE C, et al. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: A randomised controlled trial[J]. Gut, 2018, 67(12): 2156-2168. DOI: 10.1136/gutjnl-2017-314634.
|
[11] |
ENDO K, OIKAWA T, KAKISAKA K, et al. The impact of portal vein thrombosis on the prognosis and liver function of nonmalignant cirrhotic patients[J]. Scand J Gastroenterol, 2018, 53(10-11): 1340-1346. DOI: 10.1080/00365521.2018.1503327.
|
[12] |
NERY F, CHEVRET S, CONDAT B, et al. Causes and consequences of portal vein thrombosis in 1, 243 patients with cirrhosis: Results of a longitudinal study[J]. Hepatology, 2015, 61(2): 660-667. DOI: 10.1002/hep.27546.
|
[13] |
BERRY K, TAYLOR J, LIOU IW, et al. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2015, 13(3): 585-593. DOI: 10.1016/j.cgh.2014.10.010.
|
[14] |
LUCA A, CARUSO S, MILAZZO M, et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis[J]. Radiology, 2012, 265(1): 124-132. DOI: 10.1148/radiol.12112236.
|
[15] |
D'AMICO G, DE FRANCHIS R, Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators[J]. Hepatology, 2003, 38(3): 599-612. DOI: 10.1053/jhep.2003.50385.
|
[16] |
Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
|
[17] |
Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for hepatitis C(2019 version)[J]. J Clin Hepatol, 2019, 35(12): 2670 -2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008.
中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2670-2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008.
|
[18] |
National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for alcoholic liver disease: A 2018 update[J]. J Clin Hepatol, 2018, 34(5): 939-946. DOI: 10.3969/j.issn.1001-5256.2018.05.006.
中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 酒精性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34(5): 939-946. DOI: 10.3969/j.issn.1001-5256.2018.05.006.
|
[19] |
TANG W, WANG Y, ZHAO XY, et al. Impact of portal vein thrombosis on prognosis of patients with liver cirrhosis[J]. J Clin Hepatol, 2017, 33(3): 466-471. DOI: 10.3969/j.issn.1001-5256.2017.03.014.
汤雯, 王宇, 赵新颜, 等. 门静脉血栓对肝硬化患者预后的影响[J]. 临床肝胆病杂志, 2017, 33(3): 466-471. DOI: 10.3969/j.issn.1001-5256.2017.03.014.
|
[20] |
QI X, DAI J, YANG M, et al. Association between portal vein thrombosis and survival in non-liver-transplant patients with liver cirrhosis: A systematic review of the literature[J]. Gastroenterol Res Pract, 2015, 2015: 480842. DOI: 10.1155/2015/480842.
|
[21] |
AMITRANO L, GUARDASCIONE MA, MANGUSO F, et al. The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: Refining short-term prognosis and risk factors[J]. Am J Gastroenterol, 2012, 107(12): 1872-1878. DOI: 10.1038/ajg.2012.313.
|
[22] |
CHEN PH, CHEN WC, HOU MC, et al. Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: A cohort study[J]. J Hepatol, 2012, 57(6): 1207-1213. DOI: 10.1016/j.jhep.2012.07.038.
|
[23] |
FERREIRA CN, RODRIGUES T, ALEXANDRINO P, et al. Portal vein thrombosis in cirrhotic patients is associated with advanced liver disease and predicts poor long-term prognosis[J]. Hepatology, 2010, 52: 1072a. DOI: 10.1002/hep.23995.
|
[24] |
GIRLEANU I, STANCIU C, COJOCARIU C, et al. Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients[J]. Saudi J Gastroenterol, 2014, 20(5): 288-292. DOI: 10.4103/1319-3767.141687.
|
[25] |
SENZOLO M, RIVA N, DENTALI F, et al. Long-term outcome of splanchnic vein thrombosis in cirrhosis[J]. Clin Transl Gastroenterol, 2018, 9(8): 176. DOI: 10.1038/s41424-018-0043-2.
|
[26] |
Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)[J]. J Clin Hepatol, 2020, 36(12): 2667-2674. DOI: 10.3969/j.issn.1001-5256.2020.12.007.
中华医学会消化病学分会肝胆疾病学组. 肝硬化门静脉血栓管理专家共识(2020年, 上海)[J]. 临床肝胆病杂志, 2020, 36(12): 2667-2674. DOI: 10.3969/j.issn.1001-5256.202.12.007.
|
[27] |
FRANCOZ C, BELGHITI J, VILGRAIN V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: Usefulness of screening and anticoagulation[J]. Gut, 2005, 54(5): 691-697. DOI: 10.1136/gut.2004.042796.
|
[28] |
SCHMASSMANN A, ZUBER M, LIVERS M, et al. Recurrent bleeding after variceal hemorrhage: Predictive value of portal venous duplex sonography[J]. AJR Am J Roentgenol, 1993, 160(1): 41-47. DOI: 10.2214/ajr.160.1.8416643.
|
[29] |
ATTILI AF, LUPO M, GIGLIOTTI F, et al. Portal vein thrombosis is a risk factor for death and complications in liver cirrhosis[J]. Dig Liver Dis, 2012, 44(Suppl 2): s107. DOI: 10.1016/S1590-865828122960291-6.
|
[30] |
JOHN BV, KONJETI R, AGGARWAL A, et al. Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis[J]. Ann Hepatol, 2013, 12(6): 952-958. DOI: 10.1016/S1665-2681(19)31301-8.
|
[31] |
HUNG HH, CHANG CJ, HOU MC, et al. Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: A randomized controlled trial[J]. J Hepatol, 2012, 56(5): 1025-1032. DOI: 10.1016/j.jhep.2011.12.021.
|
[32] |
PERARNAU JM, BAJU A, D'ALTEROCHE L, et al. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis[J]. Eur J Gastroenterol Hepatol, 2010, 22(9): 1093-1098. DOI: 10.1097/MEG.0b013e328338d995.
|